These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1590532)

  • 21. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control and therapy of lipid storage diseases: present status and future strategies.
    Brady RO
    Ala J Med Sci; 1982 Apr; 19(2):161-4. PubMed ID: 7103002
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases.
    Imaizumi M; Gushi K; Kurobane I; Inoue S; Suzuki J; Koizumi Y; Suzuki H; Sato A; Gotoh Y; Haginoya K
    Acta Paediatr Jpn; 1994 Feb; 36(1):30-6. PubMed ID: 8165905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane.
    Scaggiante B; Pineschi A; Sustersich M; Andolina M; Agosti E; Romeo D
    Transplantation; 1987 Jul; 44(1):59-61. PubMed ID: 3037739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Graft of cryopreserved human amniotic epithelial cells in a subject with type B Niemann-Pick disease].
    Scaggiante B; Pineschi A; Sustersich M; Andolina M; Agosti E; Romeo D; Marzari R
    Pediatr Med Chir; 1987; 9(1):89-92. PubMed ID: 3628058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
    Brady RO; James SP; Barranger JA
    Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
    [No Abstract]   [Full Text] [Related]  

  • 27. New prospects for the treatment of lysosomal storage diseases.
    Schiffmann R; Brady RO
    Drugs; 2002; 62(5):733-42. PubMed ID: 11929328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid histochemical studies of lysosomal lipid metabolism diseases].
    Dietzmann K; Mohnike D
    Acta Histochem Suppl; 1984; 30():211-3. PubMed ID: 6201955
    [No Abstract]   [Full Text] [Related]  

  • 29. Substrate reduction therapy of glycosphingolipid storage disorders.
    Aerts JM; Hollak CE; Boot RG; Groener JE; Maas M
    J Inherit Metab Dis; 2006; 29(2-3):449-56. PubMed ID: 16763917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in the treatment of lysosomal diseases in infancy].
    Gutiérrez-Solana LG
    Rev Neurol; 2006 Oct; 43 Suppl 1():S137-44. PubMed ID: 17061181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses.
    Muenzer J; Neufeld EF; Constantopoulos G; Caruso RC; Kaiser-Kupfer MI; Pikus A; Danoff J; Berry RR; McDonald HD; Thompson JN
    J Inherit Metab Dis; 1992; 15(1):25-37. PubMed ID: 1533888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer approaches to the lysosomal storage disorders.
    Barranger JA; Rice EO; Swaney WP
    Neurochem Res; 1999 Apr; 24(4):601-15. PubMed ID: 10227692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
    Platt FM; Jeyakumar M; Andersson U; Priestman DA; Dwek RA; Butters TD; Cox TM; Lachmann RH; Hollak C; Aerts JM; Van Weely S; Hrebícek M; Moyses C; Gow I; Elstein D; Zimran A
    J Inherit Metab Dis; 2001 Apr; 24(2):275-90. PubMed ID: 11405346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation for metabolic diseases.
    Parkman R; Crooks G; Kohn DB; Lenarsky C; Weinberg K
    Cancer Treat Res; 1995; 76():87-96. PubMed ID: 7577346
    [No Abstract]   [Full Text] [Related]  

  • 35. Lysosomal storage disorders.
    Vellodi A
    Br J Haematol; 2005 Feb; 128(4):413-31. PubMed ID: 15686451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present status of amniocentesis in intrauterine diagnosis of genetic defects.
    Nadler HL; Gerbie A
    Obstet Gynecol; 1971 Nov; 38(5):789-99. PubMed ID: 5114231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and prenatal diagnosis of lysosomal storage diseases.
    Shi HP; Guo YF; Zhang WM; Yuan LF; Luo HY; Sun NH; Zhao SM; Zhu MG
    Chin Med J (Engl); 1988 Jun; 101(6):383-7. PubMed ID: 3146466
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.
    Desnick RJ; Schuchman EH
    Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempt at enzyme replacement in Gaucher disease by renal transplantation.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Acta Paediatr Scand; 1979 Jul; 68(4):475-9. PubMed ID: 380259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
    Muraine M; Descargues G; Franck O; Villeroy F; Toubeau D; Menguy E; Martin J; Brasseur G
    J Fr Ophtalmol; 2001 Oct; 24(8):798-812. PubMed ID: 11894530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.